• Skip to primary navigation
  • Skip to main content

IMMUNOLOGY2024™

May 3–7, 2024 | Chicago, Illinois

  • Policies
  • Program
    • President’s Program
    • Distinguished Lectures
    • Major Symposia
    • Special Session
    • Committee Sponsored Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Sessions
    • Guest Sessions
    • AAI Business Meeting
    • Exhibitor Workshops
    • Social Events
  • Register
    • Registration FAQ
  • Hotels
  • Awards
  • Careers
    • For Job Seekers
    • For Employers
    • Jobs Board
  • Abstracts
    • Abstract FAQ
    • Submission Tips
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Abstract Topic Categories
    • Major Symposium Guidance for Trainees
    • Abstract Policies and Procedures
    • Program Acknowledgements
  • Exhibitors
  • Sponsors
  • Resources
    • Attendee Social Media Toolkit
    • Presenter Social Media Toolkit
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
  • FAQ
    • General FAQ
    • Abstract FAQ
    • Registration FAQ
  • Show Search
Hide Search
IMMUNOLOGY2024™ Banner

Late-Breaking Abstract Submission Fees

Fees for AAI Members
$110

Fees for Nonmembers
 $160

Submit Your Abstract

Important Abstract Dates

Late-Breaking
Abstract Submissions Open

 Tue. Jan. 2 at 5 PM ET

Late-Breaking
Abstract Submissions Close

 Tue. Jan. 23 at 11:59 PM ET

No Edits/Revisions to Late-Breaking Submissions After
 Tue. Jan. 23 at 11:59 PM ET*

* No revisions may be made to any abstract submitted during the regular submission period.

Invitations to Present
 First week of Mar. 2024

Invitation Acceptance Due
 Fri. Mar. 15 at 12 PM ET

Deadline to Withdraw
 Fri. Mar. 15 at 12 PM ET

Abstract Submission Tips

Tips for Quality Abstracts: What Reviewers Want to See

As you draft your abstract, keep in mind the criteria reviewers will use to evaluate your work.

Originality

  • Were novel concepts or approaches used?
  • Does the abstract challenge existing paradigms or develop new methodologies or technologies?
  • If the abstract presents an extension or a replication of previous work, is the new study better than previous ones, and therefore adds genuinely new information to present knowledge, or provide clear information that was in doubt due to small sample sizes or other design issues?

Scientific Merit; Importance

  • Does the abstract address an important problem?
  • How was scientific knowledge advanced?
  • What will be the effect of the results on the concepts or methods that drive the field?
  • Are the results and conclusions strong enough to influence how clinicians/teachers/researchers “act,” understand the basic mechanisms of health/disease, or provide health services or trainee education, conduct future research, or impact public policy?

Quality of Research Design and Data Analysis

  • Is the study design clearly described?
  • Are sampling procedures adequately described, including inclusion and exclusion criteria?
  • Is there potential selection bias in the sampling procedure and is there enough information for the reviewer to be able to evaluate this problem?
  • Are possible confounding factors discussed and/or controlled for?
  • Are issues of reliability and validity of the measures addressed?
  • Are the statistical analyses appropriate for the study design?
  • Are the statistical analyses the best that could have been used?
  • Is there an adequate discussion of the statistical power of the study?

Conclusions

  • Are conclusions clearly stated?
  • How well are the conclusions justified by the data?
  • Are conclusions correct but overstated for the strength of the study?

Quality of Presentation

  • Is the abstract clearly written and understandable?
  • Has the researcher followed the directions for submission, e.g., are unique abbreviations spelled out clearly the first time they are used?

Formatting

Title:

  • The title will be published as submitted—no edits are possible after the submission deadline
  • Make each word count—don’t use too many words.
  • Use either title case (first letter of all words capitalized) or sentence case (only first word capitalized).
  • DO NOT USE ALL CAPS for your title.

Co-authors and Typos:

  • Check your abstract carefully before submitting to make sure you have included all co-authors in the proper order and have indicated the presenting author. AAI cannot add authors after the submission deadline.
  • Check for typos— AAI is not able to correct typos after submission.
  • DO NOT USE ALL CAPS for your name and your colleagues’ names.
  • Do not write names in all lower case. The abstract submission platform does not auto correct for capitalization; it will display names as they are entered.

Other Formatting Items:

  • Italics, underline, bold, superscript and subscript formatting, Greek characters (both upper and lowercase), scientific characters, charts, tables, and graphs are accepted.
  • Always keep an original copy of your submitted abstract.
  • Always proofread your abstract. Accepted abstracts will be published as submitted. If English is not your first language, please have a fluent English speaker review your abstract for conference abstract editing. 
  • Include a concise statement of the research under investigation and its objectives. Define all concepts and abbreviations at first use. Describe experimental methods briefly (including relevant numbers of patients and/or microorganisms). Describe specific findings and analysis of data (promises such as “to be completed” are not acceptable). Include specific conclusions, with supporting statistical analyses when appropriate (concluding statements such as “the results will be discussed” are not acceptable).
  • Drug products mentioned in the abstract should be identified by their non-proprietary (e.g. generic) name only. Do not capitalize non-proprietary names.
AAI Logo

Footer

IMMUNOLOGY2024™

May 3–7, 2024
McCormick Place
Chicago, Illinois, USA

Copyright © 2025 The American Association of Immunologists. All rights reserved.